Texas leads the nation in its commitment to the war on cancer. CPRIT has funded 1123 awards for cancer research, product development, and prevention since 2010. The total amount awarded thus far is $1,779,589,844.
Recipients of CPRIT awards include 98 academic institutions, non-profit organizations, and private companies all located in Texas. The research and prevention efforts funded by CPRIT advance the health of Texans, research superiority of the state, life science infrastructure, and the Texas economy. These projects are operating in virtually all regions of the state with Texas-based employees.
There are four ways to search the grants listed below.
Simple: Enter your search term into the search box above the column you would like to filter. For example, to see grants located in Austin, enter "austin" into the search box above City.
Or: To search for grants that contain lung or brain, enter "lung or brain" into the search box above Cancer Type.
And: To search for grants that contain both lung and brain, enter "lung and brain" into the search box above Cancer Type.
Multiple: To search for grants located in Houston that focus on lung cancer, enter "houston" into the search box above City and "lung" into the search box above Cancer Type.
|Grant ID||Title||Program||Primary Investigator/ Program Director||Institution/ Organization||Cancer Type||Grant Award Date||Contracted Amount|
|CC121004||Biobetter Cancer Monoclonal Antibody Program||PDEV||Holtz, Richard||Caliber Biotherapeutics||Leukemia, Lymphoma||2011/11/02||$12,808,151|
|CC121020||Novel targeted biologics, Engineered Toxin Bodies (ETB), as cancer therapeutics||PDEV||Kim, Jason||Molecular Templates, Inc.||Lymphoma||2011/11/02||$10,600,000|
|CP120014||Expanding the Market and Success Rates for Myeloablative Cancer Treatments Using PUL-042, an Innate Immune Stimulant||PDEV||Scott, Brenton||Pulmotect, Inc.||Breast, Leukemia, Lymphoma, Ovary||2012/03/29||$7,126,398|
|CP120017||Clinically Actionable Mutation Profiling for Cancer Personalized Medicine using Scalable, Ultra-deep Next Generation Sequencing||PDEV||Latham, Gary||Asuragen, Inc.||All Sites||2012/03/29||$6,837,265|
|CP120036||TexCITE (Texas Cancer ImmunoTherapy Enterprise): Focused development of innovative cell therapies for cancer||PDEV||Sando, Gregg||Cell Medica||Lymphoma, Other||2012/03/29||$15,571,303|
|CP120038||Formation of The Texas Cancer Therapeutics Process Development Lab||PDEV||Farrell, Gerry||Fujifilm Diosynth Biotechnologies Texas, LLC.||All Sites||2012/03/29||$7,901,420|
|CP130013||Clinical Development and Commercialization of Oncolytic Adenovirus for Treating Malignant Glioma||PDEV||Tufaro, Frank||DNAtrix, Inc.||Brain and Other Nervous System||2014/02/19||$10,813,623|
|CP130020||Androgen Receptor N-Terminus Blocker Program for Prostate Cancer||PDEV||Wood, David||ESSA Pharma Inc.||Bone, Other, Prostate||2014/02/19||$12,000,000|
|CP130023||Novel Ceramide-modulating Therapeutics for Cancer Use||PDEV||Love, Richard||CerRx, Inc.||Lymphoma||2014/02/19||$6,000,000|
|CP130058||Developing Two Clinical Proof of Concept Drugs that Inhibit a Novel Cancer Cell Target||PDEV||Northrup, Jonathan||Beta Cat Pharmaceuticals, LLC||Colorectal, Leukemia||2014/02/19||$15,908,085|
|DP140031||Pre-IND Development, Phase I Clinical Trials, & Predictive Biomarker Evaluation, for Engineered Human Arginase Targeting the Metabolic Vulnerability of Tumors||PDEV||Lowe, David||AERase, Inc.||Bladder, Brain and Other Nervous System, Gallbladder, Head and Neck, Kidney and Renal Pelvis, Leukemia, Liver and Intrahepatic Bile Duct, Lymphoma, Melanoma, Myeloma, Pancreas, Prostate, Sarcoma||2014/05/21||$19,806,145|
|DP140034||Preclinical Drug Discovery and Development of Novel, First-In-Class, Small Molecule Compounds That Directly Target Glioblastoma and Other Brain Cancers||PDEV||Stein, Gregory||Curtana Pharmaceuticals, Inc.||Brain and Other Nervous System, Childhood and Adolescent||2014/08/20||$7,580,185|
|DP140067||Preclinical and Clinical Development of Synergistic MicroRNA + Targeted Drug Combinations||PDEV||O'Neill, Vincent||Mirna Therapeutics, Inc.||Gallbladder, Liver and Intrahepatic Bile Duct, Lung and Bronchus||2014/05/21||$16,765,076|
|DP140072||OncoNano Medicine: Transforming Cancer Surgery by Tumor Illumination||PDEV||Sumer, Baran||OncoNano Medicine||Breast, Head and Neck, Melanoma, Skin||2014/08/20||$6,000,000|
|DP150005||Wireless neuromodulation treatment for bladder dysfunction secondary to cancer||PDEV||Duke, Austin||Nuviant Medical Inc.||Cervix Uteri, Prostate||2015/05/20||$967,000|
|DP150021||Development of Rhenium Nanoliposomes for Cancer Therapy||PDEV||Brenner, Andrew||NanoTx Therapeutics||Brain and Other Nervous System||2015/02/18||$2,000,000|
|DP150029||Personalized Cellular Immunotherapy against Novel Cancer Targets||PDEV||Steffen, Walter||Immatics US Inc.||Brain and Other Nervous System, Pancreas||2015/02/18||$19,652,175|
|DP150031||A Multi-Targeted Approach for Recurrent Glioblastoma and Other Aggressive Cancers: Exploiting the Potential of IL-4 Fusion Proteins Treatment of Cancer||PDEV||Merchant, Fahar||Medicenna Therapeutics, Inc.||Brain and Other Nervous System||2015/02/18||$14,140,090|
|DP150039||Armada Pharmaceuticals Inc. New Company Formation for Development of Anti-Cancer Antibody-Drug Conjugate Therapeutics||PDEV||Tikhomirov, Ilia||Formation Biologics Corporation||Breast, Head and Neck, Lung and Bronchus, Stomach||2015/02/18||$12,750,000|
|DP150127||Engineered AXL Decoy Receptor for Treatment of AML & Solid Tumors||PDEV||Giaccia, Amato||Ruga Corporation||Leukemia, Ovary, Pancreas||2015/11/19||$20,000,000|
|DP160012||Pelican Therapeutics||PDEV||Hornblower, Josiah||Pelican Therapeutics||Bladder, Brain and Other Nervous System, Breast, Colorectal, Corpus and Uterus, NOS, Endocrine, Gallbladder, Head and Neck, Kidney and Renal Pelvis, Leukemia, Liver and Intrahepatic Bile Duct, Lung and Bronchus, Lymphoma, Melanoma, Ovary, Pancreas, Prostate, Sarcoma, Stomach, Thyroid||2016/05/18||$15,245,222*|
|DP160014||Salarius Pharmaceuticals - Developing epigenetic drugs that treat Rare Pediatric Cancers||PDEV||Arthur, David||Salarius Pharmaceuticals LLC||Breast, Leukemia, Prostate, Sarcoma||2016/05/18||$18,668,717|
|DP160057||Clinical Evaluation of a Novel T Cell Therapy (BPX-501) for the Treatment of Children and Adults with AML||PDEV||Moseley, Annemarie||Bellicum Pharmaceuticals, Inc.||Leukemia||2016/11/16||$16,946,716*|
|DP160071||A novel compound targeting CD38 for the treatment of multiple myeloma||PDEV||Kim, Jason||Molecular Templates, Inc.||Myeloma||2016/11/16||$15,200,000*|
|R1009||Company Recruitment, Relocation and Formation||PDEV||Kutzkey, Tim||Peloton Therapeutics, Inc.||Lung and Bronchus, Multiple Sites||2010/06/18||$11,044,931|
|RP100963||Enrichment Filter and Point-of-use Assay Platform for Detection of Circulating Tumor Cells||PDEV||Vykoukal, Jody||Ingeneron, Inc.||Multiple Sites||2010/01/20||$198,111|
|RP101009||MRI-Guided Laser Therapy for Targeted Treatment of Localized Prostate Cancer||PDEV||Gowda, Ashok||Visualase, Inc.||Prostate||2010/01/20||$2,151,776|
|RP101216||Medical Devices for the Treatment of Cancerous Lesions and the Gastrointestinal Tract||PDEV||McWilliams, Dennis||Apollo Endosurgery||Colorectal, Esophagus, Stomach||2010/06/18||$5,001,063|
|RP101219||Cancer Treatment Including Drug Discovery/Development and Clinical Trials||PDEV||Ward, Ana||Mirna Therapeutics, Inc.||Basic Science, Multiple Sites||2010/06/18||$10,297,454|
|RP101287||Cancer Biology and Genetics Including Oncogenesis Genomics and Proteomics||PDEV||Mapes, James||Rules-Based Medicine||Multiple Sites||2010/06/18||$3,024,432|
|RP110508||Clinical Development of CaspaCIDe, a Cell Therapy Safety Switch||PDEV||Slawin, Kevin||Bellicum Pharmaceuticals, Inc.||Leukemia, Lymphoma, Myeloma||2011/03/24||$5,680,310|